We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SURG:NASDAQSurgePays, Inc. Analysis

Data as of 2026-06-22 - not real-time

$0.42

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SurgePays posted a 51% jump in revenue and topped 200,000 wireless subscribers, yet its operating margins remain deeply negative and cash flow is still a drain. Price is trading well below the 20‑day, 50‑day and 200‑day SMAs, RSI sits in the mid‑30s and the MACD is bearish, placing the stock near its technical support around $0.40 while volatility is sky‑high and beta exceeds one. The fundamentals are strained – negative gross, operating and profit margins, a sizable debt load, and a book value per share that is below zero, all of which underscore a precarious financial footing.
On the valuation side, the stock trades at a minuscule price‑to‑sales multiple (~0.17) and a forward PE near 8.4, and analysts project a target price of $3.50, implying a potential upside of several hundred percent. While the upside narrative is compelling, the combination of cash burn, high leverage, and extreme price swings injects significant risk, suggesting that investors should weigh the upside against the fragile balance sheet before committing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering at technical support with bearish momentum
  • Elevated volatility and beta increase short‑term uncertainty
  • Negative cash flow and high debt constrain immediate upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust 51% revenue growth and expanding subscriber base
  • Ultra‑low price‑to‑sales ratio offering valuation cushion
  • Rising trading volume indicating growing market interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic positioning in fintech and MVNO services with upside potential
  • Analyst target price suggests multi‑hundred percent upside
  • Potential to improve margins as scale and operational efficiencies are realized

Key Metrics & Analysis

Financial Health

Revenue Growth51.10%
Profit Margin-64.91%
P/E Ratio8.4
ROA-170.27%
P/B Ratio-0.4
Op. Cash Flow$-18880468
Free Cash Flow$-5059820
Industry P/E16.7

Technical Analysis

TrendBearish
RSI36.6
Support$0.40
Resistance$0.62
MA 20$0.50
MA 50$0.56
MA 200$1.50
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Target Price$3.50
Upside/Downside732.54%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.28
Volatility88.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.